Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 18, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Jun 18, 2019 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 | |
| Jun 04, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| May 17, 2019 | Director | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 02, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Apr 15, 2019 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Apr 15, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Apr 15, 2019 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 | |
| Apr 08, 2019 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Apr 03, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.